Skip to main content

TGA Approves Record Number Of Medical Cannabis Applications - HempGazette

TGA Approves Record Number Of Medical Cannabis Applications - HempGazette

TGA Australia and medical cannabis

Australia’s Therapeutic Goods Administration (TGA) had a busy July in relation to approving applications for medicinal cannabis products.

Australia’s Special Access Scheme (SAS) enables suitably authorised health practitioners to access therapeutic products not included in the Australian Register of Therapeutic Goods (ARTG). The only cannabis product currently included in the ARTG is Sativex (nabiximols), which contains THC (tetrahydrocannabinol) and CBD (cannabidiol).

There are several different pathways to gaining approval for cannabis medications through the SAS – categories A, B and C. Medical cannabis applications are generally via the Category B pathway.

Up to 31 July 2020, the TGA had approved more than 56,000 SAS Category B applications for unapproved medicinal cannabis products. That number is a cumulative figure over a very long period of time – since 1992, so nearly 30 years.

Approval numbers have certainly picked up in the last year or so. Updated figures from the TGA indicate 5,564 approvals were issued last month, so nearly 10% of all approvals ever made under SAS Category B occurred in July this year. July’s figures were well up on June’s (4,630) and more than double July last year (2,207).

What’s not clear from the figures are the numbers of different types of medicinal cannabis products are being approved, but the chances are in many cases these are cannabidiol-based.

It’s quite possible the TGA could have less workload (and doctors/patients less hassle) in this respect reasonably soon.

Back in April[1], the TGA commenced a consultation on altering the Schedule 4 listing for cannabidiol and adding  a new entry that would see some CBD preparations available without a prescription from pharmacies. An initial decision[2] will be made public next month, followed by another consultation period and then public notice of a final decision on November 25 this year.

The thousands of applications currently being approved by the TGA each month only covers the tip of demand for medicinal cannabis in Australia. Last month we mentioned a survey report stating just 3.9% of Australians[3] who used cannabis for medical purposes obtained it by prescription. Another recently released study put the figure even lower, finding just 2.7 per cent[4] were accessing legal products.

References

  1. ^ Back in April (hempgazette.com)
  2. ^ An initial decision (hempgazette.com)
  3. ^ just 3.9% of Australians (hempgazette.com)
  4. ^ finding just 2.7 per cent (hempgazette.com)

Let's block ads! (Why?)



https://hempgazette.com/news/tga-cannabi...ns-hg1236/

from potads - All Forums learn more

Popular posts from this blog

Martha Stewart launches CBD line in crowded market - CNN

Martha Stewart launches CBD line in crowded market - CNN The hemp-derived, cannabidiol-rich gummies, soft gels and oil drops officially launched on Thursday after more than a year in development. The products are the result of the style maven's partnership with Canopy Growth ( CGC ) , the Canadian cannabis company with a multibillion-dollar backer in US alcohol giant Constellation Brands ( STZ ) . Stewart joined Canopy as an adviser in early 2019 for the express purpose of developing cannabis products for humans and their pets after being introduced to Canopy's founder by her friend Calvin Broadus Jr. -- the rapper and businessman better known as Snoop Dogg. His Leafs by Snoop cannabis brand is produced by Canopy. The initial Martha Stewart CBD products, which range from $34.99 to $44.99, will be sold online at Canopy's e-commerce site . The pet products are expected to debut later this year. "I was surprised to learn that while most people have heard of ...
Read more

The Half-Legal Cannabis Trap - POLITICO

The Half-Legal Cannabis Trap - POLITICO LOS ANGELES — Everything about Kelvin’s job in a neighborhood southwest of downtown seemed like any other assignment, if not a little more exciting. The 40-year-old, who had previously worked as an electrician, had been employed since 2015 by a private security company that contracted him out to guard marijuana dispensaries. In 2019, he was protecting one of the thousand or so cannabis stores in California’s biggest city—part of an industry that has grown less and less underground since 1996, when the state first legalized medical marijuana. Kelvin, who asked not to be identified beyond his middle name to avoid professional retaliation, doesn’t smoke pot, but says the gig felt like the future. He grew up in a time when other Black people he knew in Los Angeles would go to jail for possessing even small amounts of the drug. Now, customers could walk into shops like the one he was guarding, many of which can be identified by green crosses on...
Read more

Cannabis news worldwide -- Some Indian farmers are turning moon-gazers

Some Indian farmers are turning moon-gazers A growing number of cultivators opt for biodynamic techniques to give farming a zodiac twist Sarvdaman Patel , 69, stands between rows of legumes and parsley at high noon, but it is not the harsh sun that bothers him. He is obsessed with the moon. "It is currently in the Air sign which is ideal for flowering plants," he remarks, peering at the marigolds. Patel is no Bejan Daruwala. He is an Indian farmer who has been using biodynamic (BD) techniques for the last 16 years on his farm in Gujarat's Anand. The BD cultivation calendar is based on the moon's movement through each zodiac every two-and-a-half days covering all 12 signs every month. An unofficial estimate by the Biodynamic Association of India (BDAI) says about one lakh farmers in Maharashtra, Andhra Pradesh, Punjab and Uttarakhand practise biodynamic farming. However, most of the produce is sold under the generic 'organic' label as few consumers unde...
Read more